Non-Small Cell Lung Cancer

This page contains recent news articles, when available, and an overview of Non-Small Cell Lung Cancer but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

News: Non-Small Cell Lung Cancer

Opiate Painkillers May Encourage Spread Of Cancer  -  23 Nov 2009
Medical News TodayThey used two different models of of non-small cell lung cancer and showed that MNTX inhibited the tumor-promoting effects of opiates. ...

Nereus Pharmaceuticals Presents Positive Interim Data from the ADVANCE Study ...  -  23 Nov 2009
Earthtimes (press release)The ADVANCE (Assessment of Docetaxel and Vascular Disruption in Non-Small Cell Lung Cancer) trial is investigating plinabulin in combination with docetaxel ...

Avastin not recommended for treatment of GBM  -  23 Nov 2009
Pharmacy Europe...treatment of the advanced stages of four common types of cancer: colorecta cancer, breast cancer, non-small cell lung cancer NSCLC) and kideney cancer. ...

Agennix AG Reports Financial Results For Third Quarter and First Nine Months ...  -  23 Nov 2009
PR-Inside.com (Pressemitteilung)The Company's most advanced program is talactoferrin, an oral targeted therapy that is in Phase 3 clinical trials in non-small cell lung cancer. ...

OXiGENE Reports Positive Safety Data From Phase 2 Trial of ZYBRESTAT in Non ...  -  ‎Nov 17, 2009‎
CNNMoney.com (press release)A Phase II study in platinum-resistant ovarian cancer has been completed and a non-small cell lung cancer study combining fosbretabulin with bevacizumab and ...

ASCO Releases Updated Treatment Guidelines for Patients with Stage 4 Non-Small ...  -  ‎Nov 22, 2009‎
Media Newswire (press release)New recommendations on the use of chemotherapy to treat patients with stage 4 non-small cell lung cancer (NSCLC) were issued today by the American Society ...

Basilea presents new research data on oncology drug candidate BAL27862 at ...  -  ‎Nov 18, 2009‎
CNNMoney.com (press release)...on Molecular Targets and Cancer Therapeutics reveal that BAL27862 has impressive activity against a panel of non small cell lung cancer cell lines, ...

ASTRO: Radiation Beneficial in Non-Small Cell Lung Cancer Cranial irradiation ...  -  ‎Nov 3, 2009‎
ModernMedicine2 (HealthDay News) -- In patients with non-small cell lung cancer, prophylactic cranial irradiation may help prevent brain metastases, and stereotactic ...

EU Panel: Affirm Benefits Of Celvapan, Focetria, Pandemrix  -  ‎Nov 20, 2009‎
CNNMoney.com...a generic of Taxotere, which is authorized in the European Union for the treatment of breast cancer, non-small-cell lung cancer, prostate cancer, ...

Merck Serono: CHMP Opinion for Erbitux in Advanced Non-Small Cell Lung Cancer  -  ‎Nov 20, 2009‎
PharmiWeb.com (press release)For more information on Erbitux in colorectal, head & neck and non-small cell lung cancer, please visit: www.globalcancernews.com.

Poniard cancer drug misses goal in lung cancer  -  ‎Nov 16, 2009‎
The Associated PressPoniard was running a late-stage trial of picoplatin as a secondary treatment for non-small cell lung cancer, meaning the drug was given to patients who had ...

Cytokinetics Announces Non-Clinical Data Relating to GSK-923295 Presented at ...  -  ‎Nov 19, 2009‎
CNNMoney.com (press release)The authors concluded that RNAi phenotype profiling of non-small cell lung cancer cells identified significant pathways that suggest synergistic ...

What's New in...Lung Cancer  -  ‎Nov 16, 2009‎
American Journal of Hemotology and OncologyEffectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre ...

NovaRx Corporation Announces FDA Approval of Protocol Amendment to Special ...  -  ‎Nov 4, 2009‎
ReutersLucanix® consists of four non-small cell lung cancer cell lines that have been gene-modified to block a molecule called transforming growth factor-beta ...

Oz Plus: Lung Cancer in Women  -  ‎Nov 11, 2009‎
myfoxny.com...the cells lining air passages, according to the National Cancer Institute, The two main types are small cell lung cancer and non-small cell lung cancer. ...

Abraxis BioScience Reports 2009 Third Quarter Financial Results  -  ‎Nov 5, 2009‎
ReutersThe majority of the increase was due to additional spending on Phase III clinical trials for non-small cell lung cancer, pancreatic cancer and melanoma. ...

ODAC will Review Tarceva for Maintenance Therapy in Advanced Non-Small Cell ...  -  ‎Nov 17, 2009‎
Trading Markets (press release)...for patients with advanced non-small cell lung cancer (NSCLC) who have not progressed following first-line treatment with platinum-based chemotherapy at ...

Study resets the risk, benefits of preventive radiation  -  ‎Nov 12, 2009‎
Cancerfacts.com11, 2009 – A new study taking a closer look at the risks and benefits of brain radiation therapy to prevent non-small cell lung cancer from spreading to the ...

Exelixis Reports Encouraging Phase 1 Data for the PI3K Inhibitor Xl147 ...  -  ‎Nov 18, 2009‎
WELT ONLINETumor types include non-small cell lung cancer (NSCLC) (8), colorectal cancer (5), hepatocellular carcinoma, head and neck squamous cell carcinoma, ...

Corporate Watch  -  ‎Oct 28, 2009‎
Wall Street JournalAgency to use the drug in combination with chemotherapy to treat advanced, non-small-cell lung cancer in patients who had tried other cancer therapies. ...

New Treatment Option Emerging For Some With Early Stage Lung Cancer  -  ‎Nov 3, 2009‎
Science Daily (press release)3, 2009) — Patients with early stage, non-small cell lung cancer who are not able to undergo surgery, now have a highly effective treatment option. ...

Novelos Therapeutics and Academic Collaborators Present Scientific Findings at ...  -  ‎Nov 16, 2009‎
WELT ONLINENOV-002 is in a pivotal Phase 3 trial for non-small cell lung cancer under a Special Protocol Assessment (SPA) and Fast Track, which is expected to conclude ...

FDA Panel To Review OSI Pharma's Tarceva As First-line Maintenance Therapy In ...  -  ‎Nov 16, 2009‎
RTT News...advanced non-small cell lung cancer who have not progressed following first-line treatment with platinum-based chemotherapy at its December 16 meeting. ...

Why you should pack in smoking for good  -  ‎Nov 13, 2009‎
St. Helens StarThere are two main types of primary lung cancer, small cell lung cancer and non small cell lung cancer. They respond to treatments quite differently. ...

Synta Presents Preclinical Data on Next Generation Hsp90 Inhibitor, STA-9090  -  ‎Nov 18, 2009‎
RTT News (press release)In vivo studies of STA-9090 demonstrated strong single agent activity in cancers such as non-small cell lung cancer, gastric carcinoma and melanoma and ...

New Markers of Prognosis for Cancer Therapies Highlighted  -  ‎Nov 18, 2009‎
PhysOrg.comScreening for mutations in the epidermal growth factor receptor (EGRF) prior to non-small cell lung cancer treatment, for example, has been shown to ...

European medical advisory committee does not recommend approval of Avastin for ...  -  ‎Nov 21, 2009‎
PipelineReview.com (press release)...treatment of the advanced stages of four common types of cancer: colorectal cancer, breast cancer, non-small cell lung cancer (NSCLC) and kidney cancer. ...

Intervals Between Lung Cancer Diagnosis And Treatment Displays A Health Care ...  -  ‎Nov 1, 2009‎
Science Daily (press release)...and his team of researchers conducted a retrospective analysis of 482 patients diagnosed with non-small cell lung cancer among a diverse population. ...

Antisoma AGM update and Interim Management Statement  -  ‎Nov 9, 2009‎
CNNMoney.com (press release)This 1200-patient study is evaluating ASA404 in combination with standard chemotherapy as a first-line treatment for non-small cell lung cancer. ...

Exelixis Reports Encouraging Phase 1 Data for the PI3K Inhibitor XL147 ...  -  ‎Nov 17, 2009‎
WELT ONLINE...will be dose-escalated up to 225 mg/m 2 and AUC 6, respectively, with expansion at the MTD in patients with non-small cell lung cancer (NSCLC). ...

Global Phase III Study Results Show Eribulin Meets Primary Endpoint of Overall ...  -  ‎Oct 30, 2009‎
Reuters...the efficacy and safety not only in breast cancer, but also in non-small cell lung cancer (NSCLC), hormone refractory prostate cancer, and sarcoma. ...

PET Imaging Response A Prognostic Factor After Thoracic Radiation Therapy For ...  -  ‎Nov 7, 2009‎
Science Daily (press release)6, 2009) — A rapid decline in metabolic activity on a PET scan after radiation therapy for non-small cell lung cancer is correlated with good local tumor ...

CHMP turns Erbitux down again for metastatic NSCLC  -  ‎Nov 20, 2009‎
Pharma Times...with platinum-based chemotherapy for the treatment of patients with epidermal growth factor receptor-expressing metastatic non-small cell lung cancer. ...

OXiGENE to Present at American Society of Hematology and AACR/NCI/EORTC Meetings  -  ‎Nov 12, 2009‎
CNNMoney.com (press release)Phase 2 study of ZYBRESTAT(TM) in combination with Avastin(R) (bevacizumab) and chemotherapy in patients with advanced non-small cell lung cancer at a ...

Age should not affect chemotherapy choice for stage IV lung cancer: guidelines  -  ‎Nov 17, 2009‎
Curetoday.com (press release)NEW YORK (Reuters Health) - In an update to its 2003 guidelines for stage IV non-small-cell lung cancer (NSCLC) chemotherapy, the American Society of ...

Idera Pharmaceuticals Reports Third Quarter 2009 Financial Results and ...  -  ‎Nov 5, 2009‎
Reuters..."We are pleased to have presented clinical data of IMO-2055 in renal cell cancer and in non-small cell lung cancer. We look forward to presenting data from ...

Duke University Initiates Study of AEOL 10150 to Measure Compound's Ability to ...  -  ‎Nov 17, 2009‎
Earthtimes (press release)Non-Small Cell Lung Cancer is one of the most common cancers in the United States, with more than 170000 cases diagnosed each year. ...

Moffitt wins $19 million in stimulus grants  -  ‎Nov 19, 2009‎
Tampa Bay Business Journal...$2.1 million to Srikumar Chellappan to examine the role of the human gene ID1 in the progression of non-small-cell lung cancer. ...

Questions and answers on the recommendation for the refusal of a change to the ...  -  ‎Nov 20, 2009‎
PharmaLive.com (press release)It is already used in combination with other medicines to treat cancer of the colon or rectum (large intestine), breast cancer, non-small cell lung cancer ...

No Reduction in Transfusions with ESAs  -  ‎Nov 10, 2009‎
MedPage TodayThey identified 56210 patients who were diagnosed with diffuse large B-cell lymphoma, breast cancer, non-small cell lung cancer, or colon cancer over a ...

Cancer Treatment Guidelines for Diverse Asian Economies Use Model Developed at ...  -  ‎Oct 30, 2009‎
Reuters...positive breast cancer, neck cancer, T-cell and natural-killer-cell neoplasms, advanced non-small-cell lung cancer, liver cancer and endometrial cancer. ...

UPDATE 3-EU panel blocks Merck KGaA's Erbitux in lung cancer  -  ‎Nov 19, 2009‎
路透中国Merck's initial application had been for use of Erbitux injections in combination with standard chemotherapy to combat non-small cell lung cancer (NSCLC), ...

BUSINESS WIRE: Erbitux Recognized by ASCO as a 2009 Major Cancer Advance as ...  -  ‎Nov 16, 2009‎
Vereinigte WirtschaftsdiensteFor more information on Erbitux in colorectal, head & neck and non-small cell lung cancer, please visit: www.globalcancernews.com. ...

Video-Assisted Surgery Helps Lung Cancer Patients  -  ‎Nov 19, 2009‎
North American Press SyndicateMany of the estimated 180000 Americans who will be diagnosed with non-small cell lung cancer-the most common form of lung cancer-this year may be able to ...

Infinity's IPI-504 Named One of Windhover and Campbell Alliance's "Top 10 ...  -  ‎Nov 17, 2009‎
CNNMoney.com (press release)Infinity is also enrolling patients with non-small cell lung cancer (NSCLC) in a Phase 1b study evaluating IPI-504 in combination with Taxotere(R) ...

Allos Therapeutics, Inc., Q3 2009 Earnings Call Transcript  -  ‎Nov 3, 2009‎
Seeking Alpha (blog)The result of the completed studies of FOLOTYN in non-small cell lung cancer led to the design of our ongoing Phase 2b randomized multi-center international ...

ArQule Announces Third Quarter Fiscal 2009 Results  -  ‎Nov 5, 2009‎
ReutersRecent Operational Highlights ARQ 197: * Completion of patient enrollment in the Phase 2 non-small cell lung cancer (NSCLC) trial testing the combination ...

PET imaging useful in lung cancer cases  -  ‎Nov 10, 2009‎
United Press International10 (UPI) -- US scientists say a rapid decline in metabolic activity on a PET scan after radiation for non-small cell lung cancer suggests good local tumor ...

EM011 activates a survivin-dependent apoptotic program in human non-small cell ...  -  ‎Oct 31, 2009‎
7thSpace Interactive (press release)In A549 human non-small cell lung cancer cells, the antiproliferative activity was mediated through blockage of cell-cycle progression by induction of a ...

MethylGene Reports Favorable Phase I Data for MGCD265 in Solid Tumors at the ...  -  ‎Nov 17, 2009‎
Market Wire (press release)...its Phase II program with MGCD265 in combination with Tarceva ® (erlotinib) and docetaxel, focused on non-small cell lung cancer (NSCLC) patients. ...



Background information on Non-Small Cell Lung Cancer [When available]

Lung cancer is a malignant tumour of the lungs. Most commonly it is bronchogenic carcinoma (about 90%). Lung cancer is the most lethal malignant tumour worldwide, causing up to 3 million deaths annually.

The most important risk factor for lung cancer is smoking.

Treatment and prognosis depend upon the histological type of cancer and the stage (degree of spread). Possible treatment modalities include surgery, chemotherapy) and/or radiotherapy.

Search the web for more resources on Non-Small Cell Lung Cancer



Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy